Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Genital Psoriasis”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Post-approval studies (Phase 4)Study completedNCT05969223
What this trial is testing

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Who this might be right for
Genital PsoriasisScalp Psoriasis
AbbVie 214
Large-scale testing (Phase 3)Study completedNCT03777436
What this trial is testing

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

Who this might be right for
Psoriasis
Amgen 289
Not applicableNot Yet RecruitingNCT06802848
What this trial is testing

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Who this might be right for
Plaque PsoriasisPsoriatic ArthritisScalp Psoriasis+3 more
Chongqing Genrix Biopharmaceutical Co., Ltd 1,000
Large-scale testing (Phase 3)Study completedNCT02718898
What this trial is testing

Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis

Who this might be right for
Genital PsoriasisPsoriasis
Eli Lilly and Company 149
Large-scale testing (Phase 3)Active Not RecruitingNCT06611163
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Who this might be right for
Moderate to Severe Genital Psoriasis
Sun Pharmaceutical Industries Limited 206